February 12, 2016 / 7:12 AM / 2 years ago

BRIEF-Biogaia: to distribute and list IBT subsidiary

Feb 12 (Reuters) - Biogaia Ab

* Says proposes distribution and separate listing of Infant Bacterial Therapeutics (IBT) subsidiary

* To finance IBT’s first clinical trial, company has capital need of around SEK 100 mln, planned to be raised through a rights issue in Q2 with preferential rights for IBT’s shareholders

* Mar 29 set to be first day of trading in IBT’s shares on Nasdaq First North Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below